CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2018

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Pharmacoepidemiology of antihypertensive drugs in a tertiary care hospital, Madhya Pradesh, India

Author: 
Prabhakar Singh, Pallavi Indurkar, Amita Singh, Roshani Shrivastava, Bhupendra Raj and Arun Kumar Shrivastava
Subject Area: 
Health Sciences
Abstract: 

Aims and Objectives: The aim of study is to determine the frequency and prescribing pattern of antihypertensive drugs in Out Patient Department of a tertiary care hospital and to identify whether the pattern of prescribing is appropriate in accordance with national and international guidelines for pharmacotherapy of hypertension. Methods: This is a prescription-based survey; the prescriptions were collected randomly from OPDs of SGM Hospital in form of Xerox copy after taking the consent, the total 3587 prescriptions were analyzed. Results: In the 3587 prescriptions total 8144 drugs were prescribed; of these only 4.19% (342) drugs were belonging to cardiovascular groups. Amongst the cardiovascular drugs 94.73% (324) were belongs to antihypertensive and 5.26% were to anti-CHF (drugs) groups. 91.35% drugs were prescribed as monotherapy and 8.64% as combination therapy. The CCBs (Amlodipine 83.47%) were the most frequently prescribed (35.49%) antihypertensive followed by ACEIs 25% (Enalapril 60.49%), β-blockers 13.27% (Atenolol 69.76%), AT1 antagonist or ARBs 9.25% (Losartan 80.0%), combination therapy 8.64% (AT+AM = LO+HCTZ 46.42%) and diuretics 8.33% (Hydrochlorothiazide 55.55% 27). However over all prescribing frequency amongst antihypertensive drugs were as follow; Amlodipine (29.63%) ≥ Enalapril (15.12%) ≥ Ramipril (9.87%) ≥ Atenolol ≥ (9.25%) ≥ Losartan (7.40%) hydrochlorothiazide ≥ (4.63%) ≥ Es-amlodipine (4.32%) ≥ AT+AM (4.01%)= LO+HCTZ (4.01%) ≥ Frusemide (3.70%) ≥ Candesartan (1.85%) ≥ Metoprolol (1.54%) and others. Conclusions: Most of antihypertensive in this study were prescribed as monotherapy. CCBs; Amlodipine was most frequently prescribed antihypertensive followed by Enalapril ≥ Ramipril ≥ Atenolol ≥ and Losartan, in combination therapy AT+AM and LO+HCTZ were equally prescribed. The pattern of this study were appears to be in accordance with the national and international guidelines.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran